Geneos Wealth Management’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History
Bought
Maintained
Sold
Other funds holding BSTZ
SCM
RCM
PCM
WS
Geneos Wealth Management's BSTZ Position: Q3 2025 in Review
Geneos Wealth Management sold out of BlackRock Science and Technology Term Trust (BSTZ) in Q3 2025, closing a stake of 2,218 shares — an estimated $46K sold.
Geneos Wealth Management first reported a position in BSTZ in Q4 2022 and held it in 3 quarters. The position peaked at $79.7K in Q1 2025. 114 funds tracked by Wall St. Rank hold BSTZ as of Q3 2025.
- Geneos Wealth Management reported no remaining BlackRock Science and Technology Term Trust position as of Q3 2025 after selling out during the quarter.
- Geneos Wealth Management sold 2,218 BlackRock Science and Technology Term Trust shares in Q3 2025, an estimated $46K.
- Geneos Wealth Management first reported a position in BlackRock Science and Technology Term Trust in Q4 2022 and held it in 3 quarters.
- Geneos Wealth Management's BlackRock Science and Technology Term Trust position peaked at $79.7K in Q1 2025.
- 114 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q3 2025.
Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.